SimonMed has rolled out a new digital-health platform that delivers mammography reports directly to patients’ mobile devices, using AI to interpret images plus personalized risk data aiming to improve follow-up and early detection of breast cancer.
Glimpse:
Instead of the usual static report, women now receive an interactive mobile report via a HIPAA-compliant portal: results, educational videos, an AI health-guide chat, and access to a human navigator for questions or scheduling follow-up imaging if needed. The system builds on SimonMed’s existing AI-enhanced mammography program that analyses breast density and lifetime risk, delivering a data-driven, patient-friendly output.
SimonMed Imaging a leading outpatient medical imaging provider in the U.S. with over 170 centers has announced the launch of an AI-driven mobile mammogram reporting system, aimed at transforming how women receive, understand and act on their breast-screening results.
Under this new platform, once a mammogram is done through SimonMed’s AI-enhanced screening service (Mammogram+), the report is not just a static PDF: patients can view results on their phones, watch educational content, consult an AI health assistant via chat, and directly connect with a human navigator to clarify findings or arrange follow-up diagnostics. The offering is designed to address a persistent issue many women skip recommended follow-up imaging due to lack of clarity, fear, or logistic barriers. SimonMed’s leadership argues that early detection only saves lives if it is followed by timely action.
The AI-powered reporting is built on SimonMed’s earlier adoption of advanced AI tools for breast cancer detection: their “Mammogram+ / Personalized Breast Cancer Detection (PBCD)” service already uses AI software including AI-based image analysis and risk stratification combined with radiologist oversight to detect subtle abnormalities that could be missed otherwise.
By offering a personalized mobile experience, SimonMed hopes to increase patient engagement, improve the rate of completed follow-ups, and ultimately detect more cancers at an earlier and more treatable stage. As per company statement, this kind of technology-driven patient support could help close the gap between screening and diagnosis especially for women with dense breast tissue or higher lifetime risk.
“Early detection only saves lives if it’s followed by timely action our AI-powered mobile reports turn screening results into understandable, actionable guidance that helps women take control of their breast health.”
By
HB Team
